![Hepatitis B virus vaccination booster does not provide additional protection in adolescents: a cross-sectional school-based study | BMC Public Health | Full Text Hepatitis B virus vaccination booster does not provide additional protection in adolescents: a cross-sectional school-based study | BMC Public Health | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1471-2458-14-991/MediaObjects/12889_2014_Article_7304_Fig1_HTML.jpg)
Hepatitis B virus vaccination booster does not provide additional protection in adolescents: a cross-sectional school-based study | BMC Public Health | Full Text
![Uptake of hepatitis B vaccination and its determinants among health care workers in a tertiary health facility in Enugu, South-East, Nigeria | BMC Infectious Diseases | Full Text Uptake of hepatitis B vaccination and its determinants among health care workers in a tertiary health facility in Enugu, South-East, Nigeria | BMC Infectious Diseases | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12879-018-3191-9/MediaObjects/12879_2018_3191_Fig1_HTML.png)
Uptake of hepatitis B vaccination and its determinants among health care workers in a tertiary health facility in Enugu, South-East, Nigeria | BMC Infectious Diseases | Full Text
![Nabi-HB® [Hepatitis B Immune Globulin (Human)] | Acute Exposure to HBV :: ADMA Biologics, Inc. - Nabi-HB Nabi-HB® [Hepatitis B Immune Globulin (Human)] | Acute Exposure to HBV :: ADMA Biologics, Inc. - Nabi-HB](https://s3.amazonaws.com/content.stockpr.com/nabihb/files/pages/nabi-hb-for-general-population/threat-of-hbv/percents.jpg)
Nabi-HB® [Hepatitis B Immune Globulin (Human)] | Acute Exposure to HBV :: ADMA Biologics, Inc. - Nabi-HB
Observational Study of Vaccine Efficacy 24 Years after the Start of Hepatitis B Vaccination in Two Gambian Villages: No Need for a Booster Dose | PLOS ONE
![Vaccines | Free Full-Text | Persistence of Anti-Hbs after up to 30 Years in Health Care Workers Vaccinated against Hepatitis B Virus Vaccines | Free Full-Text | Persistence of Anti-Hbs after up to 30 Years in Health Care Workers Vaccinated against Hepatitis B Virus](https://www.mdpi.com/vaccines/vaccines-09-00323/article_deploy/html/images/vaccines-09-00323-g001-550.jpg)
Vaccines | Free Full-Text | Persistence of Anti-Hbs after up to 30 Years in Health Care Workers Vaccinated against Hepatitis B Virus
![Persistence of hepatitis B surface antibody and immune memory to hepatitis B vaccine among medical college students in Madinah | Annals of Saudi Medicine Persistence of hepatitis B surface antibody and immune memory to hepatitis B vaccine among medical college students in Madinah | Annals of Saudi Medicine](https://www.annsaudimed.net/cms/asset/6f304f17-df9d-4079-b754-a62feaebeebe/0646-oa_ig.jpg)
Persistence of hepatitis B surface antibody and immune memory to hepatitis B vaccine among medical college students in Madinah | Annals of Saudi Medicine
![Vaccination at the forefront of the fight against hepatitis B and C | Nature Reviews Gastroenterology & Hepatology Vaccination at the forefront of the fight against hepatitis B and C | Nature Reviews Gastroenterology & Hepatology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41575-021-00570-x/MediaObjects/41575_2021_570_Fig1_HTML.png)
Vaccination at the forefront of the fight against hepatitis B and C | Nature Reviews Gastroenterology & Hepatology
![Missed hepatitis B birth dose vaccine is a risk factor for incomplete vaccination at 18 and 24 months - ScienceDirect Missed hepatitis B birth dose vaccine is a risk factor for incomplete vaccination at 18 and 24 months - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0163445318302871-fx1.jpg)
Missed hepatitis B birth dose vaccine is a risk factor for incomplete vaccination at 18 and 24 months - ScienceDirect
Hepatitis vaccination adherence and completion rates and factors associated with low compliance: A claims-based analysis of U.S. adults | PLOS ONE
![Immunogenicity and safety of a tri-antigenic versus a mono-antigenic hepatitis B vaccine in adults (PROTECT): a randomised, double-blind, phase 3 trial - The Lancet Infectious Diseases Immunogenicity and safety of a tri-antigenic versus a mono-antigenic hepatitis B vaccine in adults (PROTECT): a randomised, double-blind, phase 3 trial - The Lancet Infectious Diseases](https://www.thelancet.com/cms/attachment/91dbf75b-2288-4086-9df9-adddee7ae55e/gr1_lrg.jpg)
Immunogenicity and safety of a tri-antigenic versus a mono-antigenic hepatitis B vaccine in adults (PROTECT): a randomised, double-blind, phase 3 trial - The Lancet Infectious Diseases
![Poor Adherence Contributes to Inadequate Uptake of Multidose Hepatitis Vaccine Schedules - Clinical Advisor Poor Adherence Contributes to Inadequate Uptake of Multidose Hepatitis Vaccine Schedules - Clinical Advisor](https://www.clinicaladvisor.com/wp-content/uploads/sites/11/2018/12/hepatitisbvaccinesh364252355_1450943-860x573.jpg)